Enanta Pharmaceuticals Inc (ENTA)
12.49
+0.49
(+4.08%)
USD |
NASDAQ |
May 31, 16:00
12.43
-0.06
(-0.48%)
After-Hours: 20:00
Enanta Pharmaceuticals Shares Outstanding: 21.18M for April 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 30, 2024 | 21.18M |
March 31, 2024 | 21.18M |
January 31, 2024 | 21.16M |
January 16, 2024 | 21.16M |
December 31, 2023 | 21.16M |
November 01, 2023 | 21.06M |
September 30, 2023 | 21.06M |
August 01, 2023 | 21.06M |
June 30, 2023 | 21.06M |
April 28, 2023 | 21.06M |
March 31, 2023 | 21.05M |
January 31, 2023 | 20.89M |
January 10, 2023 | 20.89M |
December 31, 2022 | 20.88M |
November 01, 2022 | 20.80M |
September 30, 2022 | 20.79M |
August 02, 2022 | 20.72M |
June 30, 2022 | 20.72M |
April 27, 2022 | 20.71M |
March 31, 2022 | 20.62M |
January 31, 2022 | 20.53M |
January 07, 2022 | 20.51M |
December 31, 2021 | 20.51M |
December 15, 2021 | 20.51M |
November 01, 2021 | 20.32M |
Date | Value |
---|---|
September 30, 2021 | 20.24M |
August 01, 2021 | 20.21M |
July 29, 2021 | 20.21M |
June 30, 2021 | 20.21M |
April 26, 2021 | 20.20M |
March 31, 2021 | 20.18M |
January 31, 2021 | 20.17M |
January 08, 2021 | 20.14M |
December 31, 2020 | 20.14M |
December 15, 2020 | 20.14M |
November 01, 2020 | 20.08M |
September 30, 2020 | 20.08M |
July 30, 2020 | 20.07M |
June 30, 2020 | 20.07M |
April 30, 2020 | 20.00M |
March 31, 2020 | 19.99M |
January 31, 2020 | 19.92M |
January 06, 2020 | 19.81M |
December 31, 2019 | 19.81M |
December 01, 2019 | 19.76M |
November 01, 2019 | 19.73M |
September 30, 2019 | 19.70M |
July 30, 2019 | 19.68M |
June 30, 2019 | 19.68M |
April 28, 2019 | 19.67M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
19.68M
Minimum
Jul 30 2019
21.18M
Maximum
Apr 30 2024
20.44M
Average
20.32M
Median
Nov 01 2021
Shares Outstanding Benchmarks
Madrigal Pharmaceuticals Inc | 21.31M |
Galectin Therapeutics Inc | 62.15M |
Viking Therapeutics Inc | 110.27M |
Akero Therapeutics Inc | 69.15M |
89bio Inc | 98.38M |